Health Catalyst, IncHealth Catalyst, IncHealth Catalyst, Inc

Health Catalyst, Inc

No trades
No trades

SEC filings and other documents


Explore the latest company documents and SEC filings from the company, including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.
2026
Earnings, Q2 FY2026
Aug 6, 2026
Q2 2026 beat guidance, divestiture enabled debt repayment, and 2026 outlook reflects transformation.
AGM 2026
Jul 16, 2026
Director elections, auditor ratification, and executive pay approved; board structure change failed.
Earnings, Q1 FY2026
May 11, 2026
Q1 2026 beat expectations, with Project Nexus restructuring and AI focus driving transformation.
2025
Earnings, Q4 FY2025
Annual
Mar 12, 2026
2025 saw modest revenue growth, margin expansion, and a strategic shift amid migration headwinds.
Earnings, Q3 FY2025
Nov 10, 2025
Q3 2025 outperformed guidance; 2026 revenue to dip slightly, but EBITDA to improve.
Wells Fargo 20th Annual Healthcare Conference 2025
Sep 4, 2025
Migration to Egnyte and cost-saving measures drive near-term headwinds but set up future growth.
Earnings, Q2 FY2025
Aug 7, 2025
Revenue outlook lowered on funding cuts, but profitability and EBITDA guidance reaffirmed.
Investor Presentation
May 18, 2025
Q1 2025 revenue and EBITDA surpassed guidance, fueled by high retention and AI-driven solutions.
Earnings, Q1 FY2025
May 7, 2025
Q1 revenue and EBITDA beat guidance, with Ignite driving growth and margin improvement expected.
Raymond James & Associates’ 46th Annual Institutional Investors Conference
Mar 4, 2025
Tripled revenue, tech focus, and AI-driven efficiency set up 40% annual EBITDA growth.
43rd Annual J.P. Morgan Healthcare Conference 2025
Jan 15, 2025
Double-digit growth and expanding profitability driven by tech innovation and client conversions.
2024
Earnings, Q4 FY2024
Annual
Feb 26, 2025
2025 outlook targets $335M revenue, 13% tech growth, and 40 new platform clients.
7th Annual Evercore ISI HealthCONx Conference
Dec 4, 2024
Pre-pandemic demand, Ignite-driven growth, and margin expansion set up a return to double-digit growth.
Earnings, Q3 FY2024
Nov 6, 2024
Q3 results beat guidance, with raised 2024 outlook and strong momentum for double-digit growth in 2025.
2024 Wells Fargo Healthcare Conference
Sep 4, 2024
Earnings, Q2 FY2024
Aug 7, 2024
Earnings, Q1 FY2024
May 9, 2024
Barclays 26th Annual Global Healthcare Conference 2024
Mar 14, 2024
J.P. Morgan 42nd Annual Healthcare Conference 2024
Jan 10, 2024
2023
Earnings, Q4 FY2023
Annual
Feb 22, 2024
Stephens Annual Investment Conference | NASH 2023
Nov 15, 2023
Investor Presentation
Nov 10, 2023
Earnings, Q3 FY2023
Nov 2, 2023
Investor Presentation
Aug 25, 2023